Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 15,000
- Avg volume
- —
- Day's range
- $0.01 – $0.01
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
CardioComm Solutions, Inc. develops and sells advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The company offers consumer health monitoring products, including GEMS mobile ECG, GEMS mobile RPM, HeartCheck CardiBeat Mobile ECG device, GlobalCardio, and HeartCheck SM...
Show more
CardioComm Solutions, Inc. develops and sells advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The company offers consumer health monitoring products, including GEMS mobile ECG, GEMS mobile RPM, HeartCheck CardiBeat Mobile ECG device, GlobalCardio, and HeartCheck SMART monitoring. It also provides healthcare professional monitoring products, such as GEMS Sirona, GEMS WIN, and Trident Pro 40L. CardioComm Solutions, Inc. was incorporated in 1989 and is headquartered in Toronto, Canada.
- Industry
- Health Information Services
- Sector
- Healthcare
- Phone
- 416 977 9425
- Website
- https://cardiocommsolutions.com
- Address
- 18 Wynford Drive, Suite 305 North York, Toronto, Canada
Latest news
No headlines yet.
